Bone remodeling, particle disease and individual susceptibility to periprosthetic osteolysis

被引:64
作者
Gallo, J. [1 ,2 ]
Raska, M. [3 ]
Mrazek, F. [3 ]
Petrek, M. [3 ]
机构
[1] Palacky Univ, Fac Med, Dept Orthoped, CR-77147 Olomouc, Czech Republic
[2] Univ Hosp, Olomouc, Czech Republic
[3] Palacky Univ, Fac Med, Dept Immunol, CR-77147 Olomouc, Czech Republic
关键词
periprosthetic osteolysis; particle disease; basic multicellular unit; osteoclast; osteoblast;
D O I
10.33549/physiolres.931140
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Bone remodeling is a tightly coupled process consisting of repetitive cycles of bone resorption and formation. Both processes are governed by mechanical signals, which operate in conjunction with local and systemic factors in a discrete anatomic structure designated a basic multicellular unit (BMU). The microenvironment around total joint arthroplasty is a dynamic and complex milieu influenced by the chemical and physical stimuli associated with servicing the prosthesis. A key factor limiting the longevity of the prosthesis is polyethylene wear, which induces particle disease, and this may lead to increased and prolonged activity of BMUs resulting in periprosthetic osteolysis. Several pathways regulating BMU function have been reported in the past, including RANKL/RANK/OPG/TRAF6, TNF-a/TNFR/TRAF1, and IL-6/CD126/JAK/STAT. Moreover, the expression and functional activity of all these molecules can be affected by variations in their genes. These may explain the differences in severity of bone defects or prosthetic failure between patients with similar wear rates and the same prosthesis. Simultaneously, this data strongly support the theory of individual susceptibility to prosthetic failure.
引用
收藏
页码:339 / 349
页数:11
相关论文
共 45 条
[1]  
Ambruzova Z, 2006, TISSUE ANTIGENS, V67, P528
[2]   Osteoclast signalling pathways [J].
Blair, HC ;
Robinson, LJ ;
Zaidi, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 328 (03) :728-738
[3]  
Boyce Brendan F., 2005, Keio Journal of Medicine, V54, P127, DOI 10.2302/kjm.54.127
[4]   Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease [J].
Boyce, Brendan F. ;
Schwarz, Edward M. ;
Xing, Lianping .
CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (04) :427-432
[5]   Osteoclast differentiation and activation [J].
Boyle, WJ ;
Simonet, WS ;
Lacey, DL .
NATURE, 2003, 423 (6937) :337-342
[6]   Efficacy of etanercept for wear debris-induced osteolysis [J].
Childs, LM ;
Goater, JJ ;
O'Keefe, RJ ;
Schwarz, EM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (02) :338-347
[7]   Chemokine gene activation in human bone marrow-derived osteoblasts following exposure to particulate wear debris [J].
Fritz, EA ;
Glant, TT ;
Vermes, C ;
Jacobs, JJ ;
Roebuck, KA .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 77A (01) :192-201
[8]  
Gallo Jiri, 2006, Biomedical Papers (Olomouc), V150, P135
[9]   Gene expression clustering using self-organizing maps: analysis of the macrophage response to particulate biomaterials [J].
Garrigues, GE ;
Cho, DR ;
Rubash, HE ;
Goldring, SR ;
Herndon, JH ;
Shanbhag, AS .
BIOMATERIALS, 2005, 26 (16) :2933-2945
[10]   Expression of CD9, CD11b, CD18, CD52 and PDGFR-β in the interface membrane of loose endoprostheses [J].
Guenther, R ;
Morawietz, L ;
Friederich, M ;
Gehrke, T ;
Frommelt, L ;
Schröder, JH ;
Krenn, V .
PATHOLOGY RESEARCH AND PRACTICE, 2005, 201 (06) :435-442